CROHNS DISEASE

This study looked at how safe guselkumab is for people with moderate to severe Crohn's disease. 38 adults received the drug and were monitored for side effects and how well their symptoms improved over 48 weeks. The main goal was to track any negative events, while also checking …

This study followed 646 people with complex fistulas caused by Crohn's disease or other conditions. Researchers watched how standard surgeries performed in real clinics, without changing any treatments. The goal was to learn how often fistulas heal and what complications occur af…

This early-stage study tested the safety and tolerability of a new drug called AZD7798 in 112 healthy volunteers and people with Crohn's disease. Participants received either the drug or a placebo, and researchers monitored for side effects and how the drug moved through the body…

This study watched 92 adults with inflammatory bowel disease (Crohn's or ulcerative colitis) who were taking vedolizumab as either an IV infusion or a shot under the skin. Researchers did not give any treatment but simply recorded which route patients chose, why they switched or …